Praxis Dr. med. Abdou Zarzour

At Praxis Dr. med. Abdou Zarzour in Halle, Germany, clinical research focuses on Hidradenitis Suppurativa, a chronic inflammatory skin disorder. The trials are designed to test the novel therapy remibrutinib for its ability to reduce disease activity and improve patient outcomes.

• Assessment of treatment efficacy using HiSCR50 response criteria
• Monitoring safety and tolerability over extended treatment periods
• Inclusion of both adult and adolescent participants with moderate to severe disease

Two Phase 3 studies are currently active, led by a single investigator, generating important data on a potential new option for this immune‑mediated condition.